BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14662028)

  • 1. Extragonadal germ cell tumors in Japan.
    Ebi H; Nakata M; Tahara M; Igarashi T; Kawada K; Itoh K; Ueda R; Minami H
    Cancer Sci; 2003 Dec; 94(12):1107-11. PubMed ID: 14662028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
    Bokemeyer C; Nichols CR; Droz JP; Schmoll HJ; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Hartmann JT
    J Clin Oncol; 2002 Apr; 20(7):1864-73. PubMed ID: 11919246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
    Hartmann JT; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Bokemeyer C
    Ann Oncol; 2002 Jul; 13(7):1017-28. PubMed ID: 12176779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
    Bokemeyer C; Hartmann JT; Fossa SD; Droz JP; Schmol HJ; Horwich A; Gerl A; Beyer J; Pont J; Kanz L; Nichols CR; Einhorn L
    APMIS; 2003 Jan; 111(1):49-59; discussion 59-63. PubMed ID: 12752235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence.
    Winter C; Zengerling F; Busch J; Heinzelbecker J; Pfister D; Ruf C; Lackner J; Albers P; Kliesch S; Schmidt S; Bokemeyer C
    World J Urol; 2022 Dec; 40(12):2863-2878. PubMed ID: 35554637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features and Treatment Outcomes in Patients with Extragonadal Germ Cell Tumors: A Single-center Experience.
    Makino T; Konaka H; Namiki M
    Anticancer Res; 2016 Jan; 36(1):313-7. PubMed ID: 26722059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
    Fizazi K; Pagliaro L; Laplanche A; Fléchon A; Mardiak J; Geoffrois L; Kerbrat P; Chevreau C; Delva R; Rolland F; Theodore C; Roubaud G; Gravis G; Eymard JC; Malhaire JP; Linassier C; Habibian M; Martin AL; Journeau F; Reckova M; Logothetis C; Culine S
    Lancet Oncol; 2014 Dec; 15(13):1442-1450. PubMed ID: 25456363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extragonadal germ cell tumors in Taiwan: an analysis of treatment results of 59 patients.
    Hsu YJ; Pai L; Chen YC; Ho CL; Kao WY; Chao TY
    Cancer; 2002 Aug; 95(4):766-74. PubMed ID: 12209720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term results of treatment in patients with extragonadal germ cell tumours.
    Gutierrez Delgado F; Tjulandin SA; Garin AM
    Eur J Cancer; 1993; 29A(7):1002-5. PubMed ID: 7684595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
    Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
    J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic impact of different tumor marker levels in nonseminomatous germ cell tumor patients with intermediate prognosis: A registry of the International Global Germ Cell Tumor Collaborative Group (G3).
    Seidel C; Daugaard G; Tryakin A; Necchi A; Cohn-Cedermark G; Ståhl O; Hentrich M; Brito M; Albany C; Taza F; Gerl A; Oechsle K; Oing C; Bokemeyer C
    Urol Oncol; 2019 Nov; 37(11):809.e19-809.e25. PubMed ID: 31494007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and radiographic characterization of primary seminomas and nonseminomatous germ cell tumors.
    Gu L; Zhang L; Hou N; Li M; Shen W; Xie X; Teng Y
    Niger J Clin Pract; 2019 Mar; 22(3):342-349. PubMed ID: 30837421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy of extragonadal germ cell tumors.
    Logothetis CJ; Samuels ML; Selig DE; Dexeus FH; Johnson DE; Swanson DA; von Eschenbach AC
    J Clin Oncol; 1985 Mar; 3(3):316-25. PubMed ID: 2579212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late testicular relapse two decades after primary extragonadal germ cell tumor with uncommon metastases: a case report.
    Tobiume M; Aoki S; Nishikawa G; Muramatsu H; Ono K; Morinaga S; Hara K; Ando N; Ono K; Nishibata C; Hidano A; Nakagawa M; Takahashi I; Matsubara K; Yamada Y
    J Med Case Rep; 2021 Feb; 15(1):59. PubMed ID: 33541424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extragonadal germ cell tumors: prognostic factors and long-term follow-up.
    Aparicio J; Montalar J; Munárriz EB; Reynés G; Gómez-Codina J; Pastor M; Herranz C
    Eur Urol; 1995; 28(1):19-24. PubMed ID: 8521889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of tumor marker decline as an independent prognostic factor in patients with relapsed metastatic germ-cell tumors.
    Mego M; Rejlekova K; Reckova M; Sycova-Mila Z; Obertova J; Rajec J; Mardiak J
    Neoplasma; 2009; 56(5):398-403. PubMed ID: 19580341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors.
    Kim A; Ji L; Balmaceda C; Diez B; Kellie SJ; Dunkel IJ; Gardner SL; Sposto R; Finlay JL
    Pediatr Blood Cancer; 2008 Dec; 51(6):768-73. PubMed ID: 18802946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T; Kamoto T; Hara I; Kawai K; Nakao M; Nonomura N; Kobayashi T; Ogawa O; Kamidono S; Akaza H; Okuyama A; Kato T; Miki T
    Cancer; 2003 Oct; 98(8):1635-42. PubMed ID: 14534879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
    Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
    Oncology; 1999 Jul; 57(1):1-9. PubMed ID: 10394118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histologically pure seminoma with elevated alpha-fetoprotein: a clinicopathologic study of ten cases.
    Nazeer T; Ro JY; Amato RJ; Park YW; Ordonez NG; Ayala AG
    Oncol Rep; 1998; 5(6):1425-9. PubMed ID: 9769381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.